Now is the time to prep for future pandemics

Sandra Abrevaya, cofounder and CEO of Synapticure, discusses the company's virtual ataxia care program and its aim to expand access to specialized neurologists and personalized treatment plans for people with the neurological condition.

As cases rise, Dr. Amesh Adalja, senior scholar at Johns Hopkins Center for Health Security and an infectious disease expert, explains what it would mean for measles to become established in the U.S. again.

Healthcare organizations need a risk-based and patient-centered approach for benchmarking, says Ellipsis Health cofounder and Chief Medical Officer Dr. Michael Aratow, whose company has met with HHS and other agencies on AI safety standards.